People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ImmunoGenesis, Inc. | — | Biotechnology | Series C | $50.2M | $43.0M | 2024 |
| Lucina Health, Inc. | — | Healthtech | Seed | $24.0M | $50.1M | 2010 |
Federica O'Brien at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Federica O'Brien on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Ross | 1 | 18 |
| Timothy Petersen | 1 | 9 |
| Wright Steenrod | 1 | 9 |
| Robert Stein | 1 | 6 |
| Clifford Stocks | 1 | 5 |
| George Dunbar | 1 | 5 |
| Koleman Karleski | 1 | 5 |
| Robert B. Stein | 1 | 5 |
| TED KOUTOUZIS | 1 | 4 |
| W. Earl Reed III | 1 | 4 |
| Thomas Barton | 1 | 4 |
| Eileen Maus | 1 | 3 |
| Federica Pericle | 1 | 2 |
| Timothy Peterson | 1 | 2 |
| Susan Luria | 1 | 2 |
| Kevin Bramer | 1 | 2 |
| Dean Koch | 1 | 2 |
| Meg Rush | 1 | 1 |
| Karleski Koleman | 1 | 1 |
| Timothy Petersen Petersen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.